Sanna Toppila Salmi

Airway research group aims at identifying clinical and molecular factors for better prediction of inflammatory and neoplastic airway diseases, such as non-steroidal anti-inflammatory drug (NSAID) -exacerbated respiratory disease (NERD), asthma, chronic rhinosinusitis and tongue cancer. We use such as next generation sequencing and  artificial intelligence  in analyses of clinical cohorts and randomized placebo-controlled clinical trials.